The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization
response and its evasion by emerging viral variants and variant of concern (VOC) are …

Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have emerged since the start of the COVID-19 pandemic. Over this period, we developed …

Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been recorded since January 2020. Over this time global vaccine programs …

Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-2
monoclonal antibodies and vaccines currently used in clinical practice; broadly …

Antibodies against coronavirus spike protein potently protect against infection and disease,
but whether such protection can be extended to variant coronaviruses is unclear. This is …

Effective vaccines and monoclonal antibodies have been developed against coronavirus
disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐…

DNA i-motif structures are formed in the nucleus of human cells and are believed to provide
critical genomic regulation. While the existence of i-motif structures in human cells has been …

In this study, the biocompatibility and degradation behavior of a low elastic modulus Ti-35Nb-3Zr
alloy were investigated and compared with that of the conventional orthopedic and …

Staphylococcus aureus interacts with the human immune system through the production of
secreted factors. Key among these is protein A, a B-cell superantigen capable of interacting …

We developed a repertoire approach to generate human antibody bispecifics. Using phage
display selection of antibody heavy chains in the presence of a competitor light chain and …